EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Role of vitamin D supplementation and vitamin D receptor in drug‐resistant epilepsy: A double‐blind placebo‐controlled trial conducted in India

Soumya S Pattnaik, Sudhir C Sarangi iD, Yajnaseni Dash, Archana Singh, Ravinder Goswami, Surender Singh, Maroof A Khan, Jyotirmoy Banerjee iD, Sudip K Datta, Manjari Tripathi

Epilepsia · 2025-10 · 66 (10) · 3716-3729

DOI: 10.1111/epi.18492 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Epilepsia, online erschienen am 14.06.2025. Verfasst von Soumya S Pattnaik und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India. Hauptthemen laut MEDLINE: Receptors, Calcitriol, Vitamin D, Drug Resistant Epilepsy, Dietary Supplements. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: All-India Institute of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Vitamin D has demonstrated potential anticonvulsant effects in experimental and pilot clinical studies; the results of these remain inconclusive. This study aims to investigate the efficacy and safety of adjunctive Vitamin D supplementation in reducing seizure frequency, modulating vitamin D receptor (VDR) activity, and altering the putative biomarkers of epileptogenesis in persons with drug‐resistant epilepsy (DRE).

Methods

This double‐blind, placebo‐controlled, parallel‐group, adjunctive trial recruited patients from a tertiary care hospital in India. Adult persons with DRE and serum Vitamin D levels

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CalcitriolVitamin DDrug Resistant EpilepsyDietary SupplementsHumansDouble-Blind MethodMaleFemaleIndiaAdultAnticonvulsantsMiddle AgedYoung AdultTreatment OutcomeVitamins

Stichwörter der Autor:innen

HMGB1drug‐resistant epilepsyglial cell line–derived neurotrophic factorneurotrophin‐3vitamin Dvitamin D receptor

Substanzen

Receptors, CalcitriolVitamin DAnticonvulsantsVDR protein, humanVitamins

Autor:innen und Institutionen

  • Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Bennett University, Greater Noida, Uttar Pradesh, India.
  • Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Department of Endocrinology, Metabolism and Diabetes, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • University College Sedaya International (UCSI) University, Kuala Lumpur, Malaysia.
  • Department of Biostatistics, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

ORCID-Profile: Sudhir C Sarangi, Jyotirmoy Banerjee

Förderung

  • All-India Institute of Medical Sciences

Zitieren

APA

Pattnaik, S. S., Sarangi, S. C., Dash, Y., Singh, A., Goswami, R., Singh, S., Khan, M. A., Banerjee, J., Datta, S. K., & Tripathi, M. (2025). Role of vitamin D supplementation and vitamin D receptor in drug‐resistant epilepsy: A double‐blind placebo‐controlled trial conducted in India. Epilepsia, 66(10), 3716-3729. https://doi.org/10.1111/epi.18492

Vancouver

Pattnaik SS, Sarangi SC, Dash Y, Singh A, Goswami R, Singh S, et al. Role of vitamin D supplementation and vitamin D receptor in drug‐resistant epilepsy: A double‐blind placebo‐controlled trial conducted in India. Epilepsia. 2025;66(10):3716-3729. doi:10.1111/epi.18492

BibTeX
@article{Pattnaik2025,
  author = {Pattnaik, Soumya S and Sarangi, Sudhir C and Dash, Yajnaseni and Singh, Archana and Goswami, Ravinder and Singh, Surender and Khan, Maroof A and Banerjee, Jyotirmoy and Datta, Sudip K and Tripathi, Manjari},
  title = {Role of vitamin D supplementation and vitamin D receptor in drug‐resistant epilepsy: A double‐blind placebo‐controlled trial conducted in India},
  journal = {Epilepsia},
  year = {2025},
  volume = {66},
  number = {10},
  pages = {3716--3729},
  doi = {10.1111/epi.18492}
}
Kostenlos starten →